Abstract
Estramustine phosphate has been used for over 20 years in the treatment of advanced prostate cancer. Recent reports of promising results from clinical combination studies, and neoadjuvant studies, have caused a renewed interest in this relatively old drug. After oral or intravenous administration, estramustine phosphate is metabolised to four main metabolites: estramustine, estromustine, estradiol and estrone. Due to the potential biological activity of all these estramustine phosphate metabolites, it is necessary to analyse the parent compound and all four metabolites in plasma, tissues and tumours. Consequently, various methods have been developed for the bioanalysis of these compounds. In this review various methods are described for the analysis of estramustine phosphate and its metabolites in biological fluids and tissues. Methods described included RIA, TLC, HPLC, HPLC-MS, GC and GC-MS.
Keywords: nor-nitrogen mustard conjugate, prostate cancer, plasma clearance, bioavailability, high first-pass metabolism, non-chromatographic assay procedure, estradiol, chromatography, spectrometry, estrone
Current Pharmaceutical Analysis
Title: A Short Review of Analytical Methods for the Determination of Estramustine Phosphate and its Metabolites in Biological Samples
Volume: 1 Issue: 2
Author(s): Massimo Breda and Christopher A. James
Affiliation:
Keywords: nor-nitrogen mustard conjugate, prostate cancer, plasma clearance, bioavailability, high first-pass metabolism, non-chromatographic assay procedure, estradiol, chromatography, spectrometry, estrone
Abstract: Estramustine phosphate has been used for over 20 years in the treatment of advanced prostate cancer. Recent reports of promising results from clinical combination studies, and neoadjuvant studies, have caused a renewed interest in this relatively old drug. After oral or intravenous administration, estramustine phosphate is metabolised to four main metabolites: estramustine, estromustine, estradiol and estrone. Due to the potential biological activity of all these estramustine phosphate metabolites, it is necessary to analyse the parent compound and all four metabolites in plasma, tissues and tumours. Consequently, various methods have been developed for the bioanalysis of these compounds. In this review various methods are described for the analysis of estramustine phosphate and its metabolites in biological fluids and tissues. Methods described included RIA, TLC, HPLC, HPLC-MS, GC and GC-MS.
Export Options
About this article
Cite this article as:
Breda Massimo and James A. Christopher, A Short Review of Analytical Methods for the Determination of Estramustine Phosphate and its Metabolites in Biological Samples, Current Pharmaceutical Analysis 2005; 1 (2) . https://dx.doi.org/10.2174/1573412054022716
DOI https://dx.doi.org/10.2174/1573412054022716 |
Print ISSN 1573-4129 |
Publisher Name Bentham Science Publisher |
Online ISSN 1875-676X |
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
- Announcements
Related Articles
-
Wnt Signaling and Prostate Cancer
Current Drug Targets Design, Synthesis and Biological Evaluation of Salicylamide Analogues as Epidermal Growth Factor Receptor Tyrosine Kinase Inhibitors
Letters in Drug Design & Discovery Subject Index to Volume 4
Current Gene Therapy Telomere Maintenance as Therapeutic Target in Embryonal Tumours
Anti-Cancer Agents in Medicinal Chemistry Relaxin as a Cardiovascular Hormone: Physiology, Pathophysiology and Therapeutic Promises
Cardiovascular & Hematological Agents in Medicinal Chemistry The Interaction of Dietary Fibres with the Colon
Current Nutrition & Food Science Thymoquinone Anticancer Discovery: Possible Mechanisms
Current Drug Discovery Technologies Antioxidant, Anti-Inflammatory and Anticancer Activities of the Methanolic Extract of Thottea siliquosa: An <i>In Vitro</i> and <i>In Silico</i> Study
Recent Patents on Anti-Cancer Drug Discovery Pharmacological Modulation of Caspase Activation
Current Medicinal Chemistry - Anti-Inflammatory & Anti-Allergy Agents An Unprecedented Revolution in Medicinal Chemistry Driven by the Progress of Biological Science
Current Topics in Medicinal Chemistry Toxicity of Ionic Liquids Towards Mammalian Cell Lines
Current Organic Chemistry A Comparative Study on <i>In vitro</i> Anti-cancer and <i>In vivo</i> Anti-angiogenic Effects of TRPC Blockers Pyr-3 and SKF-96365
Letters in Drug Design & Discovery Docking and Virtual Screening to Identify PKC Agonists: Potentials in Anticancer Therapeutics
Current Computer-Aided Drug Design Silencing of Disease-related Genes by Small Interfering RNAs
Current Molecular Medicine Honey as a Source of Dietary Antioxidants: Structures, Bioavailability and Evidence of Protective Effects Against Human Chronic Diseases
Current Medicinal Chemistry Cancer-Targeting Multifunctionalized Gold Nanoparticles in Imaging and Therapy
Current Medicinal Chemistry Oleic Acid Protects Against Oxidative Stress Exacerbated by Cytarabine and Doxorubicin in Rat Brain
Anti-Cancer Agents in Medicinal Chemistry Can γH2AX be Used to Personalise Cancer Treatment?
Current Molecular Medicine Alam K et al. (2018) Drug Metabolism Letters; 12, 24-32.
Drug Metabolism Letters Perspectives on the Role of P21-Activated Kinase 1 (PAK1) in the Intestinal Anti-inflammatory and Antitumor Potential of Artepillin C
Current Molecular Pharmacology